Literature DB >> 10942847

To model a psychiatric disorder in animals: schizophrenia as a reality test.

B K Lipska1, D R Weinberger.   

Abstract

Animal modeling has been instrumental in dissecting pathophysiological mechanisms and designing more effective therapies in many areas of medicine but not so in psychiatry. The critical obstacle in modeling psychiatric disorders has been limited information about their origin and underlying neural mechanisms. Recently, with rapidly growing knowledge about the neurobiology and genetics of psychiatric disorders, animal models of these diseases are gaining popularity in psychiatric research. New models of schizophrenia mimic biological phenomena associated with the clinical condition, particularly developmental changes in the cortex, abnormalities of glutamate neurotransmission, and genetic characteristics of selected behavioral traits. The biological fidelity of some aspects of these new models suggests that they will be useful in the development of new therapies, in identifying candidate genes, and in providing new insights about pathophysiology and etiology.

Entities:  

Mesh:

Year:  2000        PMID: 10942847     DOI: 10.1016/S0893-133X(00)00137-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  163 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

Authors:  Yukiori Goto; Patricio O'Donnell
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

3.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

4.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

5.  A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus.

Authors:  Barbara K. Lipska; Daniel R. Weinberger
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

6.  Neonatal exposure to the glutamate receptor antagonist MK-801: effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats.

Authors:  R. J. Beninger; A. Jhamandas; H. Aujla; L. Xue; R. V. Dagnone; R. J. Boegman; K. Jhamandas
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 7.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

8.  Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia.

Authors:  Alma Genis-Mendoza; Ileana Gallegos-Silva; Carlos Alfonso Tovilla-Zarate; Lilia López-Narvaez; Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Mavil López-Casamichana; Humberto Nicolini; Sandra Morales-Mulia
Journal:  J Mol Neurosci       Date:  2017-12-06       Impact factor: 3.444

9.  Hyper-response to Novelty Increases c-Fos Expression in the Hippocampus and Prefrontal Cortex in a Rat Model of Schizophrenia.

Authors:  Tomas Monfil; Rubén Antonio Vázquez Roque; Israel Camacho-Abrego; Hiram Tendilla-Beltran; Tommaso Iannitti; Ivan Meneses-Morales; Patricia Aguilar-Alonso; Gonzalo Flores; Julio Cesar Morales-Medina
Journal:  Neurochem Res       Date:  2017-12-06       Impact factor: 3.996

10.  A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

Authors:  Holly Moore; J David Jentsch; Mehdi Ghajarnia; Mark A Geyer; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.